Shl Telemedicine Ltd (SHMLF) — SEC Filings
Shl Telemedicine Ltd (SHMLF) — 39 SEC filings. Latest: 6-K (Dec 3, 2025). Includes 33 6-K, 2 20-F, 2 SC 13D/A.
View Shl Telemedicine Ltd on SEC EDGAR
Overview
Shl Telemedicine Ltd (SHMLF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 3, 2025: On December 3, 2025, SHL Telemedicine Ltd. announced the successful completion of its rights offering and capital increase. The company, headquartered at 90 Yigal Alon Street in Tel Aviv, Israel, filed a Form 6-K to report this development.
Sentiment Summary
Across 39 filings, the sentiment breakdown is: 38 neutral, 1 mixed. The dominant filing sentiment for Shl Telemedicine Ltd is neutral.
Filing Type Overview
Shl Telemedicine Ltd (SHMLF) has filed 33 6-K, 2 20-F, 1 SC 13G, 1 20-F/A, 2 SC 13D/A with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (39)
Risk Profile
Risk Assessment: Of SHMLF's 36 recent filings, 0 were flagged as high-risk, 8 as medium-risk, and 28 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Key Executives
- Lior Haalman
- Amir Hai
- Orna Carni
- Dr. Itamar Offer
- David Arnon
- MATAN WULKAN
- NIR ROTENBERG
- Ilana Freundlich
- Ido Nouberger
- Victor Shamrich
- Yariv Alroy
- Professor Amir Lerman
Top Tags
corporate-governance (11) · shareholder-meeting (10) · press-release (9) · filing (5) · registration-statement (4) · sec-filing (3) · management-change (3) · amendment (3) · capital-raise (2) · annual-results (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Ordinary Shares | 5,116,734 | Represented at the annual general meeting on May 28, 2025. |
| Prime Rate (Dec 31, 2024) | 6.00% | Indicates current borrowing costs |
| Prime Rate (Dec 31, 2023) | 6.25% | Shows change in borrowing costs from prior year |
| Director Term | 3 years | Orna Carni's term as external director |
| Billed Accounts Receivable Terms | 30-60 days | Standard payment terms for the company's receivables. |
| Prime Rate (Dec 31, 2022) | 4.75% | Provides a comparison for the prime rate trend. |
| Days | 30-60 | Terms of billed accounts receivable |
| Past Due Receivables | 0 | Material billed receivables past due as of December 31, 2023 and 2022 |
| Prime Rate | 6.25% | As of December 31, 2023 |
| Year Period | 5 | Cash flow projections for goodwill valuation |
| Par Value | NIS 0.01 | Par value of SHL Telemedicine Ltd. ordinary shares |
| Ordinary Shares Voted | 6,765,828 | Represents 78.7% of voting shares at the meeting, indicating strong shareholder participation. |
| Votes Against Board Expansion | 4,387,246 | This significant number of 'Against' votes shows shareholder opposition to increasing the board size from 9 to 10 directors. |
| Votes For Director Re-election | 4,466,553 | This indicates strong shareholder support for the re-election of both Yariv Alroy and Professor Amir Lerman, ensuring continuity in leadership. |
Forward-Looking Statements
- {"claim":"SHL Telemedicine's board size will remain at a maximum of nine directors for the foreseeable future.","entity":"SHL Telemedicine Ltd.","targetDate":"2025-02-08","confidence":"high"}
- {"claim":"Yariv Alroy and Professor Amir Lerman will continue to play significant roles in the company's governance.","entity":"Yariv Alroy, Professor Amir Lerman","targetDate":"2025-02-08","confidence":"high"}
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Shl Telemedicine Ltd (SHMLF)?
Shl Telemedicine Ltd has 39 recent SEC filings from Feb 2024 to Dec 2025, including 33 6-K, 2 20-F, 2 SC 13D/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SHMLF filings?
Across 39 filings, the sentiment breakdown is: 38 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Shl Telemedicine Ltd SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Shl Telemedicine Ltd (SHMLF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Shl Telemedicine Ltd?
Financial highlights for Shl Telemedicine Ltd are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for SHMLF?
The investment thesis for SHMLF includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Shl Telemedicine Ltd?
Key executives identified across Shl Telemedicine Ltd's filings include Lior Haalman, Amir Hai, Orna Carni, Dr. Itamar Offer, David Arnon and 7 others.
What are the main risk factors for Shl Telemedicine Ltd stock?
Of SHMLF's 36 assessed filings, 0 were flagged high-risk, 8 medium-risk, and 28 low-risk.
What are recent predictions and forward guidance from Shl Telemedicine Ltd?
Recent forward-looking statements from Shl Telemedicine Ltd include guidance on {"claim":"SHL Telemedicine's board size will remain at a maximum of nine directors for the foreseeable future.","entity" and 1 other predictions.